Mark Spiecker is President of STAQ Pharma, a 503B Outsourcing Facility in Columbus, OH and Denver, Colorado that will provide sterile injectable compounded medications to hospitals across the country. Prior to joining STAQ, Marks’s career spanned a number of strategy and leadership roles. In each role Mark utilized his passion for business development, process improvement and innovative operations to successfully guide complex organizations through significant change.
Mark is the former CEO of Sharklet Technologies, Inc. a medical device firm that developed a texture inspired by Sharkskin to control bacteria on surfaces. Mark exited Sharklet to a Bioscience group out of China, providing significant returns to shareholders. Mark is an active community leader, currently serving as a Chair and Board Member of the Denver Metro Chamber of Commerce, a Trustee at the Denver Museum of Nature and Science. Prior to 2019, Mark served as Chair of the Board of the Colorado Biosciences Association.